SELECTIVE SEROTONIN REUPTAKE INHIBITOR TOXICITY

Course overview

SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) ARE COMMONLY PRESCRIBED ANTIDEPRESSANTS. OTHER CLINICAL INDICATIONS FOR SSRI USE INCLUDE ANXIETY DISORDERS, OBSESSIVE-COMPULSIVE DISORDER, PANIC DISORDERS, AND EATING DISORDERS. COMPARED TO THEIR PREDECESSORS, THE MONOAMINE OXIDASE INHIBITORS AND TRICYCLIC ANTIDEPRESSANTS, SSRIS ARE ASSOCIATED WITH FEWER TOXIC EFFECTS. THIS ACTIVITY DESCRIBES THE USES, MODE OF ACTION AND ADVERSE EFFECTS OF SSRIS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF THESE PATIENTS.